Partnership Highlights

40+
CCA-F Certified Engineers
150+
Anthropic Academy Professionals
4
Biopharma Clients on Claude via AWS Bedrock
12+
Years Life Sciences Expertise
16+
Proprietary Life Sciences AI Platforms

Why Claude, Powered by Anthropic?

Life Sciences is one of the most demanding environments for enterprise AI. Regulatory complexity, scientific depth, auditability requirements, and patient safety considerations make it a domain where general-purpose AI implementations consistently fall short.

Claude, powered by Anthropic, is purpose-suited for this challenge. Its advanced reasoning capability, long-context understanding, and responsible AI design make it the right foundation for high-stakes, compliance-grade agentic workflows — from clinical documentation to pharmacovigilance to regulatory intelligence.

Agilisium brings the domain layer that makes Claude transformative in practice — combining certified practitioners, Life Sciences process expertise, and the FDX™ delivery model to move clients from AI ambition to measurable business outcomes.

What Customers Choose — and Why

Customers do not choose a partner because of certifications alone. They choose a partner because that partner understands their business, their industry, their processes, their regulatory environment, and can deliver measurable business outcomes.

Agilisium's differentiation is therefore not simply Claude expertise — it is the combination of:

• Deep Life Sciences domain expertise — from Molecule to Market
• Customer business process knowledge embedded at every layer
• FDX™ — our end-to-end customer transformation methodology, not just a deployment model
• Context-Native AI architecture built for regulated environments
• Claude, powered by Anthropic, and its advanced reasoning capability
• Enterprise AI engineering with responsible AI by design

Context-Native AI Delivered Through FDX™

We don't parachute AI into client environments. Our Forward Deployment Experts are embedded practitioners who combine deep Life Sciences domain knowledge with hands-on Claude implementation capability. The FDX™ framework is what makes our solutions land in production - not just in pilots.

FDX™ combines:

Deep Life Sciences domain expertise
Customer business process knowledge
Context-Native AI architecture
Enterprise AI engineering
Agentic AI development
Responsible AI by design
Reusable IP and industry accelerators
Measurable outcome focus

Claude-Powered Solutions Across the Life Sciences Value Chain

6
Life Sciences Domains
16+
Proprietary AI Platforms
30%
Reduction in Documentation Time (Production)
Clinical Development

Automated clinical trial documentation, protocol digitization, Smart ICF intelligence, and study conduct agents — reducing processing time and improving protocol consistency across regulated environments.

Medical Affairs

Medical literature synthesis, scientific messaging, and MLR review acceleration — enabling Medical Affairs teams to move faster with greater confidence.

R&D & Drug Discovery

Target identification, literature review, and preclinical intelligence agents — powered by Claude's ability to synthesise and reason across large volumes of scientific data.

Regulatory Affairs

Regulatory intelligence agents and submission automation built for FDA, EMA, and ICH compliance — accelerating submissions without sacrificing accuracy.

Pharmacovigilance & Drug Safety

Pharmacovigilance narrative generation and safety signal monitoring — bringing Claude's reasoning capability to one of the highest-stakes functions in Life Sciences.

Commercial Operations

MLR review agents, field force effectiveness, speaker program management, and value dossier generation — helping commercial teams operate faster and smarter.

Claude in Production — Case Study

Clinical Trial Documentation Automation

Agilisium deployed an agentic solution using Claude Sonnet in Amazon Bedrock, powered by Anthropic, to automate clinical trial documentation across complex research workflows. The solution reduced documentation processing time by 30% and achieved 95% model reliability in a regulated, compliance-grade environment meeting 21 CFR Part 11 and GxP standards.

Frequently Asked Questions

What is the Claude Partner Network?
FAQ mark

The Claude Partner Network is Anthropic's global ecosystem for services and technology companies that build and deliver solutions powered by Claude. Select Services Partners have demonstrated production experience with Claude and meet Anthropic's standards for certified practitioners and client implementations.

How does Agilisium use Claude in Life Sciences?
FAQ mark

Agilisium leverages Claude in Bedrock, powered by Anthropic, to build agentic AI solutions for pharma and biotech clients. Current production use cases include clinical trial documentation automation, medical literature synthesis, MLR review acceleration, and pharmacovigilance narrative generation — all deployed in compliance-grade environments meeting 21 CFR Part 11 and GxP standards.

What does it mean to work with a Claude-certified partner?
FAQ mark

Agilisium has 40+ engineers certified under Claude Certified Architect – Foundations (CCA-F), Anthropic's formal technical certification for solution architects. For clients, this means every engagement is delivered by practitioners verified on Claude's architecture, safety standards, and implementation best practices — reducing deployment risk and accelerating time-to-value.

Operationalise Claude in Life Sciences

Leverage Agilisium's FDX™ expertise and certified Claude practitioners to move from AI ambition to measurable, responsible business outcomes.